OverviewChartNewsTraderScreen

BVT Call 100 6MK 21.06.2024/  DE000VM525B4  /

Frankfurt Zert./VONT
2024-05-24  10:13:38 AM Chg.+0.040 Bid11:17:36 AM Ask11:17:36 AM Underlying Strike price Expiration date Option type
2.970EUR +1.37% 2.970
Bid Size: 7,000		 3.050
Ask Size: 7,000		 MERCK CO. D... 100.00 - 2024-06-21 Call
GlobeNewswire 05-23 Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at ...
GlobeNewswire 05-23 IO Biotech to Present at Jefferies Global Healthcare Conference
GlobeNewswire 05-23 atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
GlobeNewswire 05-23 Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Pr...
GlobeNewswire 05-07 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire 05-06 Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire 05-02 Cerevance Achieves First Milestone in Research Collaboration with Merck
TeleTrader 04-25 Merck's Q1 sales rise by 9% to $15.8 billion
GlobeNewswire 04-02 Vaccinex Reports 2023 Financial Results and Provides Corporate Update
GlobeNewswire 03-06 IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Can...
GlobeNewswire 03-04 C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
TeleTrader 02-02 Merck Group to expand investment in South Korea
TeleTrader 02-01 Merck's Q4 sales up 6% to $14.6B
TeleTrader 01-27 J&J, Merck CEOs to testify before Senate on drug prices
GlobeNewswire 01-23 Unnatural Products, Inc. Enters Research Collaboration with Merck
GlobeNewswire 2023-12-21 Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire 2023-12-19 Unnatural Products, Inc. Announces $32 Million in Series A Funding Led by Merck Global Health Innova...
GlobeNewswire 2023-12-14 ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire 2023-12-12 C4 Therapeutics Announces License and Research Collaboration with Merck to Discover and Develop Degr...
GlobeNewswire 2023-12-05 HiberCell, Inc. Announces Clinical Collaboration with Merck to Evaluate HC-7366, an Activator of ISR...
GlobeNewswire 2023-12-04 Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule
GlobeNewswire 2023-11-13 Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Update
TeleTrader 2023-10-26 Merck's Q3 sales up 7% to $16B
TeleTrader 2023-10-20 Daiichi Sankyo, Merck announce collaboration on cancer drugs
GlobeNewswire 2023-10-17 ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA